Collegium Pharmaceutical (COLL) Gross Profit Growth (5y) (2021 - 2026)
Collegium Pharmaceutical (COLL) Gross Profit Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.13 Bn | 20.98 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.60 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Collegium Pharmaceutical | 1.15 Bn | 857.67 Mn | 117.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.09% |
| Dec 31, 2025 | 23.72% |
| Sep 30, 2025 | 21.80% |
| Jun 30, 2025 | 17.51% |
| Mar 31, 2025 | 20.08% |
| Dec 31, 2024 | 31.38% |
| Sep 30, 2024 | 29.88% |
| Jun 30, 2024 | 28.04% |
| Mar 31, 2024 | 29.25% |
| Dec 31, 2023 | 16.71% |
| Sep 30, 2023 | 27.15% |
| Jun 30, 2023 | 23.00% |
| Mar 31, 2023 | 30.26% |
| Dec 31, 2022 | 38.70% |
| Sep 30, 2022 | 72.75% |
| Jun 30, 2022 | 77.37% |
| Mar 31, 2022 | 93.21% |
| Dec 31, 2021 | -26.12% |
| Sep 30, 2021 | 161.24% |